Compare
Buda Juice, Inc. vs IP Strategy Holdings, Inc. vs Jones Soda Co. vs Arcadia Biosciences, Inc.
| Latest fiscal year | Buda Juice, Inc. BUDA | IP Strategy Holdings, Inc. IPST | Jones Soda Co. JSDA | Arcadia Biosciences, Inc. RKDA |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $12.61M | $10.12M | $25.30M | $4.86M |
| Revenue growth (YoY) | +11.8% | +20.4% | +42.2% | -3.7% |
| Gross margin | 44.6% | 54.9% | 26.7% | 36.2% (computed) |
| Operating margin | 27.4% | n/m | -18.8% | -51.5% |
| Net margin | 28.0% | n/m | -7.0% | -48.1% |
| Net income | $3.53M | -$137.72M | -$1.78M | -$2.34M |
| EPS (Diluted) | $0.20 | -$16.03 | -$0.01 | -$1.71 |
| Operating cash flow | $3.15M | -$15.33M | -$1.26M | -$4.74M |
| Free cash flow | $2.90M | -$15.40M | -$1.72M | -$4.74M |
| Cash & equivalents | n/a | n/a | $3.60M | $259.0K |
| Total assets | $4.97M | $108.76M | $15.23M | $6.55M |
| Total liabilities | $1.23M | $10.54M | $13.76M | $2.41M |
| Shareholders' equity | $3.74M | $98.22M | $1.47M | $4.14M |
| Return on year-end equity | 94.5% | -140.2% | -121.4% | -56.5% |
| Shares outstanding | n/a | 9.65M | 118.23M | 1.37M |
Revenue, most recent five fiscal years
| Fiscal year | Buda Juice, Inc. | IP Strategy Holdings, Inc. | Jones Soda Co. | Arcadia Biosciences, Inc. |
|---|---|---|---|---|
| Latest | $12.61M Ended 2025-12-31 | $10.12M Ended 2025-12-31 | $25.30M Ended 2025-12-31 | $4.86M Ended 2025-12-31 |
| 1 year earlier | $11.27M Ended 2024-12-31 | $8.40M Ended 2024-12-31 | $17.79M Ended 2024-12-31 | $5.04M Ended 2024-12-31 |
| 2 years earlier | n/a | $7.97M Ended 2023-12-31 | $16.67M Ended 2023-12-31 | $4.45M Ended 2023-12-31 |
| 3 years earlier | n/a | n/a | $19.09M Ended 2022-12-31 | $7.42M Ended 2022-12-31 |
| 4 years earlier | n/a | n/a | $14.79M Ended 2021-12-31 | $6.78M Ended 2021-12-31 |